Literature DB >> 19454278

Validation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) for the treatment of focal cartilage lesions.

J E J Bekkers1, Th S de Windt, N J H Raijmakers, W J A Dhert, D B F Saris.   

Abstract

OBJECTIVE: To validate the Knee Injury and Osteoarthritis Outcome Score (KOOS) for the treatment of focal cartilage lesions.
METHODS: A total of 40 patients (mean age 35+/-12 years), treated for a focal cartilage lesion in the knee were included in this study. Test-retest data were collected with an intermediate period of 2 days. Patients were asked to complete the Dutch KOOS and complementary questionnaires [short form-36 (SF-36), Lysholm, EuroQol-5D (EQ-5D)] to evaluate the clinimetric properties of the KOOS in terms of internal consistency (Cronbach's alpha), reliability [intra-class-correlation (ICC) and Bland and Altman plots], construct validity (Spearman's rank correlation), floor and ceiling effects and responsiveness.
RESULTS: The Cronbach's alpha of the KOOS subdomains and total score ranged from 0.74 to 0.96. The overall ICC of the KOOS was 0.97 while the subscales ranged from 0.87 to 0.95. The Bland and Altman plots showed a small individual variance between the two assessments in time. Spearman's rank correlations between the subscales of the KOOS and representative subscales of the SF-36, Lysholm and EQ-5D were high to moderate ranging from 0.43 to 0.70. We observed no floor effect while the largest observed ceiling effect was 10.3%. The responsiveness was moderate to large with the effect size ranging from 0.70 to 1.32 and the standardized response mean 0.61 to 0.87.
CONCLUSION: This study illustrates the validity and reliability of the KOOS in measuring the clinical condition of patients after treatment of focal cartilage lesions. This study provides a basis for the use of the KOOS for future clinical research in cartilage repair.

Entities:  

Mesh:

Year:  2009        PMID: 19454278     DOI: 10.1016/j.joca.2009.04.019

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  65 in total

1.  Autologous matrix-induced chondrogenesis combined with platelet-rich plasma gel: technical description and a five pilot patients report.

Authors:  A A M Dhollander; F De Neve; K F Almqvist; R Verdonk; S Lambrecht; D Elewaut; G Verbruggen; P C M Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-11       Impact factor: 4.342

2.  Patients with focal full-thickness cartilage lesions benefit less from ACL reconstruction at 2-5 years follow-up.

Authors:  Jan Harald Røtterud; May Arna Risberg; Lars Engebretsen; Asbjørn Årøen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-08       Impact factor: 4.342

3.  The combination of microfracture and a cell-free polymer-based implant immersed with autologous serum for cartilage defect coverage.

Authors:  A A M Dhollander; P C M Verdonk; S Lambrecht; K F Almqvist; D Elewaut; G Verbruggen; R Verdonk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-09       Impact factor: 4.342

4.  Short-term outcome of the second generation characterized chondrocyte implantation for the treatment of cartilage lesions in the knee.

Authors:  A A M Dhollander; P C M Verdonk; S Lambrecht; R Verdonk; D Elewaut; G Verbruggen; K F Almqvist
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-08       Impact factor: 4.342

5.  Cross-cultural adaptation and validation of the Saudi Arabic version of the Knee Injury and Osteoarthritis Outcome Score (KOOS).

Authors:  Saud A Alfadhel; Vishal Vennu; Ali H Alnahdi; Mohammed T Omar; Saeed H Alasmari; Zahra AlJafri; Saad M Bindawas
Journal:  Rheumatol Int       Date:  2018-06-07       Impact factor: 2.631

6.  Development of the KOOSglobal Platform to Measure Patient-Reported Outcomes After Anterior Cruciate Ligament Reconstruction.

Authors:  Cale A Jacobs; Michael R Peabody; Christian Lattermann; Jose F Vega; Laura J Huston; Kurt P Spindler; Annunziato Amendola; Jack T Andrish; Robert H Brophy; Warren R Dunn; David C Flanigan; Morgan H Jones; Christopher C Kaeding; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Emily K Reinke; Michelle L Wolcott; Brian R Wolf; Rick W Wright; Armando F Vidal
Journal:  Am J Sports Med       Date:  2018-08-03       Impact factor: 6.202

7.  Ten-Year Outcomes and Risk Factors After Anterior Cruciate Ligament Reconstruction: A MOON Longitudinal Prospective Cohort Study.

Authors:  Kurt P Spindler; Laura J Huston; Kevin M Chagin; Michael W Kattan; Emily K Reinke; Annunziato Amendola; Jack T Andrish; Robert H Brophy; Charles L Cox; Warren R Dunn; David C Flanigan; Morgan H Jones; Christopher C Kaeding; Robert A Magnussen; Robert G Marx; Matthew J Matava; Eric C McCarty; Richard D Parker; Angela D Pedroza; Armando F Vidal; Michelle L Wolcott; Brian R Wolf; Rick W Wright
Journal:  Am J Sports Med       Date:  2018-03       Impact factor: 6.202

8.  The safety and efficacy of magnetic targeting using autologous mesenchymal stem cells for cartilage repair.

Authors:  Naosuke Kamei; Mitsuo Ochi; Nobuo Adachi; Masakazu Ishikawa; Shinobu Yanada; L Scott Levin; Goki Kamei; Takaaki Kobayashi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-16       Impact factor: 4.342

9.  Osteochondritis Dissecans of the Knee: Short-Term Outcomes of a Hybrid Technique to Restore a Partially Salvageable Progeny Fragment.

Authors:  Heath P Melugin; Vishal S Desai; Bruce A Levy; Yoshinari Tanaka; Shuji Horibe; Norimasa Nakamura; Aaron J Krych
Journal:  Cartilage       Date:  2018-08-24       Impact factor: 4.634

10.  No negative effect on patient-reported outcome of concomitant cartilage lesions 5-9 years after ACL reconstruction.

Authors:  Svend Ulstein; Karin Bredland; Asbjørn Årøen; Lars Engebretsen; Jan Harald Røtterud
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-19       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.